Results 1 to 10 of about 4,127 (206)
Improvement of Aptamer Affinity by Dimerization
To increase the affinities of aptamers for their targets, we designed an aptamerdimer for thrombin and VEGF. This design is based on the avidity of the antibody, whichenables the aptamer to connect easily since it is a single-strand nucleic acid. In this
Koji Sode, Kazunori Ikebukuro
exaly +2 more sources
An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment
Lung cancer is the leading cause of cancer-related death worldwide. Its late diagnosis and consequently poor survival make necessary the search for new therapeutic targets.
Rebeca Carrión-Marchante +11 more
doaj +1 more source
Method to Determine the Optimal Aptamer-to-Bead Ratio by Using Flow Cytometry
Research on the effective attachment of aptamers to beads, which is essential for using aptamers, has made relatively little progress. Here, we demonstrate a new method based on flow cytometry to determine the optimal aptamer-to-bead ratio for aptamer ...
Sun Young Lee +5 more
doaj +1 more source
Aptamers and aptamer targeted delivery [PDF]
When aptamers first emerged almost two decades ago, most were RNA species that bound and tagged or inhibited simple target ligands. Very soon after, the 'selectionologists' developing aptamer technology quickly realized more potential for the aptamer.
Amy C, Yan, Matthew, Levy
openaire +2 more sources
The aptamer database is designed to contain comprehensive sequence information on aptamers and unnatural ribozymes that have been generated by in vitro selection methods. Such data are not normally collected in 'natural' sequence databases, such as GenBank.
Jennifer F. Lee +3 more
openaire +2 more sources
Virus recognition has been driven to the forefront of molecular recognition research due to the COVID‐19 pandemic. Development of highly sensitive recognition elements, both natural and synthetic is critical to facing such a global issue.
Mark V. Sullivan +13 more
doaj +1 more source
Aptamer Applications in Neuroscience [PDF]
Being the predominant cause of disability, neurological diseases have received much attention from the global health community. Over a billion people suffer from one of the following neurological disorders: dementia, epilepsy, stroke, migraine, meningitis, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis ...
Meric Ozturk +2 more
openaire +7 more sources
Molecularly Imprinting–Aptamer Techniques and Their Applications in Molecular Recognition
Molecular imprinting–aptamer techniques exhibit the advantages of molecular imprinting and aptamer technology. Hybrids of molecularly imprinted polymer–aptamer (MIP–aptamer) prepared by this technique have higher stability, binding affinity and superior ...
Qingqing Zhou, Zhigang Xu, Zhimin Liu
doaj +1 more source
Aptamer and aptamer pharmaceuticals [PDF]
Recently, molecule-based targeted therapy has achieved remarkable success in clinical, and opened up a new era particulraly in the field of cancer therapy. Monoclonal antibodies and small molecule inhibitors are two pillars of this field. Additionally, a single-strand nucleic acid molecule called “chemical antibody” has also attracted increasing ...
Ting Zheng, Ziyue Ma, Quan Du
openaire +1 more source
Aptamers are short nucleic acid sequences capable of specific, high-affinity molecular binding. They are isolated via SELEX (Systematic Evolution of Ligands by Exponential Enrichment), an evolutionary process that involves iterative rounds of selection and amplification before sequencing and aptamer characterization.
Andrew Kinghorn +4 more
openaire +2 more sources

